Post-traumatic Headache Refractory to Oral Analgesic Bridge Therapy: What to Do Next

In post-traumatic headache, a scheduled oral analgesic bridge is the first-line approach. When it fails to achieve adequate headache relief, a structured escalation protocol targeting the acute, refractory phase becomes the clinical priority.

Previous treatment — goals not met

A scheduled oral analgesic bridge (ibuprofen combined with acetaminophen), started within 48 hours, did not achieve the expected outcomes: decreased headache frequency and intensity over 7 days, and a greater proportion of patients returned to school after 1 week. This insufficient response is the indication for the next-line protocol.

Next-step approach (partial — full regimen via the link below)

This protocol involves acute intravenous therapy to achieve relief or reduction of the refractory headache. The complete agent selection, sequencing, and any additional interventional options are contained in the full structured regimen.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1111/head.14795

For headaches that are refractory to first-line acute oral medication, acute IV therapies (ketorolac, dopamine receptor antagonists, IV fluids), nerve block, and oral corticosteroid bridge can be considered.
Based on this evidence, we conclude that intravenous therapy with ketorolac, dopamine receptor antagonists, intravenous fluids, and possibly valproic acid may be considered for acute symptomatic relief of PTH that has been refractory to oral medications.
Oral and intravenous analgesics are used to lessen or relieve acute headache and play a central role in treating primary headache disorders.

View source ↗